We are inspiring researchers to reach their full potential with 3D in vitro models that are robust, reliable, reproducible and scalable. Learn more at https://insphero.com/https://bsky.app/profile/insphero.bsky.socialhttps://bsky.app/profile/insphero.bsky.social/post/3md3ychuqvs24Smart plates. Smart pipettes. Smarter workflows.Together with INTEGRA we’re streamlining 3D in vitro workflows from culture to dosing and readouts.See the Akura × VIAFLO workflow at SLAS 2026 in Boston at our booth #1738 and the INTEGRA booth #2608. Use the link below to learn more!23 Jan 2026 15:11 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3md3ychuqvs24https://bsky.app/profile/insphero.bsky.social/post/3mchvv6c7x22iOur acquisition of Doppl SA (Sun Bioscience technology) is now complete! Organoids + spheroids under one roof expands our human-relevant 3D biology capabilities and supports more predictive research. Excited for what’s ahead in 3D biology. Read more about this new chapter via the link below!15 Jan 2026 15:34 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mchvv6c7x22ihttps://bsky.app/profile/insphero.bsky.social/post/3mccu2dyzus23For the 3rd year in a row, InSphero received the Supplier Performance Recognition Award from Scientist.com. Driven by real platform metrics across toxicology, pharmacology, and cell-based studies. A sign that advanced in vitro models are moving from evaluation to operation. Thank you!13 Jan 2026 15:18 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mccu2dyzus23https://bsky.app/profile/insphero.bsky.social/post/3mcad4f4ki22kMASH-TAG 2026 highlights now live! We are sharing new data on 3D liver spheroids for MASH drug discovery, Survodutide responses, and anti-fibrotic validation. More details on LinkedIn (post linked in the comments). 🎯 🧪12 Jan 2026 15:09 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mcad4f4ki22khttps://bsky.app/profile/insphero.bsky.social/post/3mbythnmyb22dNew blog alert! 🆕💡NIH has launched the Standardized Organoid Modeling (SOM) Institute, a key step for scaling organoid models and supporting regulatory use alongside the FDA Modernization Acts. With DOPPL SA, InSphero is expanding its platform to link organoids + 3D systems. Blog linked below🔗09 Jan 2026 15:41 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mbythnmyb22dhttps://bsky.app/profile/insphero.bsky.social/post/3mbwcjo7un22fWhere the slopes meet the science ❄️🧪 Our Vice President of Liver Disease will share (virtually) how 3D human liver spheroids enable human-relevant in-vitro modeling for MASH drug discovery and anti-fibrotic validation at MASH-TAG 2026. Tune in: 4:40–5:00pm MST. Session highlights coming after!08 Jan 2026 15:32 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mbwcjo7un22fhttps://bsky.app/profile/insphero.bsky.social/post/3mbtquwynsk2uBridging science and strategy during Fierce JPM Week 🔬🤝 When? Jan 13–14, 2026 in San Francisco, CA! A focused forum at the intersection of science, capital, and policy, from AI-driven innovation to dealmaking and regulation. Send us a message if you are attending and would like to connect!07 Jan 2026 15:11 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mbtquwynsk2uhttps://bsky.app/profile/insphero.bsky.social/post/3mbrbd6qp6k2tWe are starting the year in San Francisco! 🌉 InSphero will be attending the 44th J.P. Morgan Annual Healthcare Meeting (Jan 12–15, 2026), with discussions spanning research, NAMs, and the practical use of 3D microtissue models. Interested in connecting there? Reach out to us to set up a meeting.06 Jan 2026 15:28 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mbrbd6qp6k2thttps://bsky.app/profile/insphero.bsky.social/post/3mboqqffro22sFDA Modernization Act 3.0 passed the U.S. Senate, bringing it closer to law and reinforcing a shift to modern, science-driven nonclinical testing. By removing outdated animal-testing language, it supports robust, human-relevant NAMs. We are excited to use this momentum at InSphero in the new year! 🚀05 Jan 2026 15:25 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mboqqffro22shttps://bsky.app/profile/insphero.bsky.social/post/3mbe2wo4yh226New year, new sphere 🌱 This year, our focus stays the same: advancing human-relevant science for better drug development decisions. Each year is a chance to sharpen our thinking, strengthen collaboration and keep improving together. Wishing you a healthy, successful and inspiring start to the year✨01 Jan 2026 09:29 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mbe2wo4yh226https://bsky.app/profile/insphero.bsky.social/post/3mb4xhli73s26👟✨ Screens off, endorphins on. We came together for the first-ever InSphero Silvesterlauf. Walking, a relaxed 2-3 km run, or running a 5 km push, moments like these remind us how important and energizing it can be to make an effort and head back to work with a clearer mind and a spring in our step.29 Dec 2025 13:38 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mb4xhli73s26https://bsky.app/profile/insphero.bsky.social/post/3maps3jtzb22g🌟 Happy Holidays from InSphero! ☃️ Thank you to our colleagues, partners, and customers for the trust and collaboration that shaped our year. This period offers an opportunity to step back from the day-to-day and appreciate shared achievements. Wishing all joy and happiness! ✨ Drawn by Adrian Weber24 Dec 2025 07:57 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3maps3jtzb22ghttps://bsky.app/profile/insphero.bsky.social/post/3mao2oqu34k2gLast week’s special at InSphero 🧀✨ Glühwein, great vibes, and even better company, followed by 20 raclettes, 2 bubbling fondue pots, and more cheese combinations than we could count. Finished with laughter and sweet conversations. We are so thankful to be a part of a creative and caring team!23 Dec 2025 15:26 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mao2oqu34k2ghttps://bsky.app/profile/insphero.bsky.social/post/3mal3ssbyfs2tSome years stand out through steady progress. Over the past year, we advanced with strong science, reliable execution, and trusted collaboration. As human-relevant in vitro approaches gain momentum, we’re proud to contribute. Thank you to everyone who made this year count! 💚22 Dec 2025 11:08 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3mal3ssbyfs2thttps://bsky.app/profile/insphero.bsky.social/post/3ma4fypqtgc2nWondering which InSphero plate fits your application?📊 Akura™ Ultra-Low Attachment and Gri3D® Hydrogel Plates support robust 3D cultures, but are optimized for different assay and data strategies. Our selection guide helps you choose the right platform. Still unsure? Learn more via the link below 🔗16 Dec 2025 15:00 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3ma4fypqtgc2nhttps://bsky.app/profile/insphero.bsky.social/post/3m7zxcoktf22iWonder why some drug candidates fail? 🔎💊 Danuglipron and Lotiglipron were both discontinued for different reasons. This highlights the importance of understanding drug safety. Human-relevant 3D liver models can help predict DILI risk and de-risk pipelines earlier. Use the link below for more info.15 Dec 2025 15:32 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m7zxcoktf22ihttps://bsky.app/profile/insphero.bsky.social/post/3m7s77cjhyc2uNovember at InSphero ✨ It was a month of science and growth: we welcomed Doppl SA, shared 3D in vitro research at ACT, MASOT, AASLD, and SDDN, launched our Bluesky account, and strengthened Swiss-EU research collaborations. Thank you for being part of it! Use the link below to stay up to date.12 Dec 2025 13:32 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m7s77cjhyc2uhttps://bsky.app/profile/insphero.bsky.social/post/3m7psev3kz22jHappy International Mountain Day! 🗻✨ Mountains shape ecosystems, reveal layers shaped over millennia and inspire exploration. We see a similar depth in 3D cell culture, opening new horizons in understanding human biology. Their stories inspire our discoveries. Learn more with the link below. 🌄11 Dec 2025 14:37 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m7psev3kz22jhttps://bsky.app/profile/insphero.bsky.social/post/3m7mzldijqc2zNew publication! Why does phenobarbital trigger liver tumors in rodents but not humans? Using our Human & Rat 3D InSight™ Liver Microtissues, Micromatrices uncovered shared receptor activation, but proliferation only in rats, revealing species-specific biomarkers. Read the publication series below.10 Dec 2025 12:08 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m7mzldijqc2zhttps://bsky.app/profile/insphero.bsky.social/post/3m7ktw2gy222lOne connected 3D ecosystem: standardized spheroids + self-organizing organoids. With Gri3D® joining the Akura™ Portfolio, we expand standardized 3D cell culture across tissues and disease models. Scalable, reproducible, and screening-ready. Learn more with the link below.09 Dec 2025 15:21 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m7ktw2gy222lhttps://bsky.app/profile/insphero.bsky.social/post/3m76gfxvwdc2pNew blog!⚡️The FDA’s draft guidance to reduce non-human primates use signals a shift toward human-relevant in vitro systems. Our 3D InSight™ Liver Microtissues deliver early human insight, mechanistic clarity, and smarter cross-species decisions for evolving safety needs. Full blog linked below.04 Dec 2025 16:48 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m76gfxvwdc2phttps://bsky.app/profile/insphero.bsky.social/post/3m73nlplnl22oA full-day photoshoot gave us a fresh look at the people, tools, and workflows behind our 3D cell culture platforms. From lab moments to product shots, we captured the precision and passion driving our work. Here’s a peek behind the scenes, more to come soon. Learn more about us via the link below.03 Dec 2025 14:18 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m73nlplnl22ohttps://bsky.app/profile/insphero.bsky.social/post/3m6z63gu67s2tCurious how 3D MPS is reshaping human-relevant biology? Join our CSO Madhu Lal Nag this Wed, Dec 3 at 10am EST for a 3RsC webinar. Hear how next-gen MPS + organ-on-chip tech strengthen early tox decisions and support 3Rs with scalable, reproducible 3D in vitro models. Register with the link below.02 Dec 2025 14:35 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m6z63gu67s2thttps://bsky.app/profile/insphero.bsky.social/post/3m6k6x5b4hk2iA new preprint shows how Gri3D® microcavity plates enable scalable, reproducible neural organoids. Now part of our portfolio, through our recent acquisition, this technology brings the precision 3D biology needs for uniform tissues, reliable mapping, and smoother workflows.🔓Pre-print linked below.26 Nov 2025 15:41 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m6k6x5b4hk2ihttps://bsky.app/profile/insphero.bsky.social/post/3m6jivtmzn22cThe EMA backs NAMs, and we bring them to life. 🌍 Europe’s new Horizon Scanning Report shows rising support for human-relevant, 3Rs-aligned models. The message is clear: non-animal, predictive testing is becoming the standard. We’re ready to help unlock this shift with our reliable 3D systems.26 Nov 2025 09:06 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m6jivtmzn22chttps://bsky.app/profile/insphero.bsky.social/post/3m6fcfqwy2c2bNew publication! USC researchers used our 3D InSight™ Human Liver Microtissues to study PFAS effects with single-cell sequencing. They found cell-type, donor, and sex-specific responses, plus disrupted lipid metabolism and immune signaling, advancing PFAS liver research. Publication linked below.24 Nov 2025 16:59 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m6fcfqwy2c2bhttps://bsky.app/profile/insphero.bsky.social/post/3m5vwnodtts2r🚀 Taking 3D biology further! Gri3D® Hydrogel Microplates + InSphero = uniform organoids, clear imaging, automation-ready workflows & scalable assays. A unified 3D model ecosystem for faster, safer therapies. #3Dbiology #organoids #Gri3D #InSphero18 Nov 2025 14:19 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m5vwnodtts2rhttps://bsky.app/profile/insphero.bsky.social/post/3m5tklk3jzc22Heading to A Coruña for SDDN 2025! Don’t miss the talk by our CEO Jan Lichtenberg: “Scaling Complexity in 3D Microtissue Platforms.” Join us on Nov 21st, from 11:00–13:00, for insights on 3D models, multi-omics data, and scalable NAMs. Let’s connect! More information linked in the comments.17 Nov 2025 15:38 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m5tklk3jzc22https://bsky.app/profile/insphero.bsky.social/post/3m5lyxls6bs2fIt’s World Diabetes Day! 🩵🌎 At InSphero, our mission is to unlock the full potential of 3D in vitro technology. Today, we reaffirm our commitment to empowering researchers worldwide to reach their full potential and ultimately find a cure for diabetes. Learn more about our islet solutions below.14 Nov 2025 15:34 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m5lyxls6bs2fhttps://bsky.app/profile/insphero.bsky.social/post/3m5gzebfiyk24Proud to strengthen Swiss–EU innovation links! Great exchange in Bern with EU Commissioner Ekaterina Zaharieva on Swiss–EU innovation on advancing science through collaboration. Thanks to SERI, Innosuisse & the European Commission for an inspiring dialogue! Photo copyright “European Union, 2025”12 Nov 2025 15:58 +0000at://did:plc:pgldt2lnqdejgri5ul6a252x/app.bsky.feed.post/3m5gzebfiyk24